DEPAS Side Effects

7013421-8 | Hepatitis Acute
on Aug 31, 2010 Male patient from ITALY , 53 years of age, was diagnosed with anxiety (What is anxiety?), platelet aggregation inhibition, hypertension, cardiovascular event prophylaxis and was treated with Depas (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute. Depas dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), MICARDIS (View Micardis Review and Micardis Label ), LASIX (View Lasix Review and Lasix Label ), HERBESSER R (View Herbesser R Review and Herbesser R Label ), ALDACTONE (View Aldactone Review and Aldactone Label ).

7009414-7 | Hepatitis Acute
Patient was taking Depas (View Usage). Patient had the following side effects: hepatitis acute on Aug 31, 2010 from ITALY Additional patient health information: Male patient , 53 years of age, was diagnosed with anxiety (What is anxiety?), platelet aggregation inhibition, hypertension, cardiovascular event prophylaxis and. Depas dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), MICARDIS (View Micardis Review and Micardis Label ), LASIX (View Lasix Review and Lasix Label ), HERBESSER R (View Herbesser R Review and Herbesser R Label ), ALDACTONE (View Aldactone Review and Aldactone Label ).

7004964-1 | Hepatitis Acute
Adverse event was reported on Aug 31, 2010 by a Male patient taking Depas (View Usage) (Dosage: ) was diagnosed with anxiety (What is anxiety?), platelet aggregation inhibition, hypertension, cardiovascular event prophylaxis and. Location: ITALY , 53 years of age, After Depas was administered, patient had the following side effects: hepatitis acute. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), MICARDIS (View Micardis Review and Micardis Label ), LASIX (View Lasix Review and Lasix Label ), HERBESSER R (View Herbesser R Review and Herbesser R Label ), ALDACTONE (View Aldactone Review and Aldactone Label ).

6985831-6 | Hepatitis Acute
on Aug 31, 2010 Male patient from ITALY , 53 years of age, was diagnosed with anxiety (What is anxiety?), platelet aggregation inhibition, hypertension, cardiovascular event prophylaxis and was treated with Depas (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute. Depas dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), MICARDIS (View Micardis Review and Micardis Label ), LASIX (View Lasix Review and Lasix Label ), HERBESSER R (View Herbesser R Review and Herbesser R Label ), ALDACTONE (View Aldactone Review and Aldactone Label ).


6011844-7 | Cerebral Circulatory Failure
on Dec 08, 2008 Female patient from JAPAN , weighting 110.2 lb, was diagnosed with cerebral ischaemia and was treated with Depas (View Usage). Patient had the following side effects: cerebral circulatory failure. Depas dosage: . During the same period patient was treated with DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), SERMION (View Sermion Review and Sermion Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5903699-3 | Disease Progression, Disseminated Intravascular Coagulation, Mucosal Haemorrhage
Patient was taking Depas (View Usage). After Depas was administered, patient had the following side effects: disease progression, disseminated intravascular coagulation, mucosal haemorrhage on Sep 26, 2008 from JAPAN Additional patient health information: Male patient , weighting 156.5 lb, was diagnosed with rectal cancer recurrent and. Depas dosage: Unk. During the same period patient was treated with LAC B (Unk) (View Lac-b Review and Lac-b Label ), DAI KENCHU TO (Unk) (View Dai-kenchu-to Review and Dai-kenchu-to Label ), GASMOTIN (Unk) (View Gasmotin Review and Gasmotin Label ), AVASTIN (View Avastin Review and Avastin Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ELPLAT (View Elplat Review and Elplat Label ). Patient was hospitalized.

5862296-9 | Cerebral Circulatory Failure
Adverse event was reported on Aug 13, 2008 by a Female patient taking Depas (View Usage) (Dosage: ) was diagnosed with cerebral ischaemia and. Location: JAPAN , weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: cerebral circulatory failure. During the same period patient was treated with DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), SERMION (View Sermion Review and Sermion Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5793793-2 | Toxic Epidermal Necrolysis
on Jun 12, 2008 Male patient from ITALY , 59 years of age, was treated with Depas (View Usage). Patient had the following side effects: toxic epidermal necrolysis. Depas dosage: . During the same period patient was treated with KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), AMINOPHYLLINE (View Aminophylline Review and Aminophylline Label ). Patient was hospitalized.

5727570-5 | Leukopenia, Neutropenia, Oesophagitis
on Apr 25, 2008 Female patient from JAPAN , 62 years of age, was treated with Depas (View Usage). After Depas was administered, patient had the following side effects: leukopenia, neutropenia, oesophagitis. Depas dosage: . During the same period patient was treated with ROPION (View Ropion Review and Ropion Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), ANPEC (View Anpec Review and Anpec Label ), OMEPRAL (View Omepral Review and Omepral Label ), MALFA (View Malfa Review and Malfa Label ), SOLANAX (View Solanax Review and Solanax Label ), MYSLEE (View Myslee Review and Myslee Label ), SELBEX (View Selbex Review and Selbex Label ). Patient was hospitalized.

5650745-0 | Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Calcium Decreased, Blood Creatinine Increased, Blood Culture Positive, Blood Fibrinogen Decreased, Blood Glucose Increased, Blood Lactate Dehydrogenase Increased, Blood Pressure Decreased
Patient was taking Depas (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood bilirubin increased, blood calcium decreased, blood creatinine increased, blood culture positive, blood fibrinogen decreased, blood glucose increased, blood lactate dehydrogenase increased, blood pressure decreased on Feb 29, 2008 from JAPAN Additional patient health information: Male patient , 78 years of age, was diagnosed with depression (What is depression?), hypertension, gastric ulcer and. Depas dosage: 1 Mg, Unk. During the same period patient was treated with DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ), NORVASC (5 Mg/day) (View Norvasc Review and Norvasc Label ), PAXIL (10 G/day) (View Paxil Review and Paxil Label ), TAKEPRON (30 Mg/day) (View Takepron Review and Takepron Label ). Patient was hospitalized.

5642338-6 | Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Calcium Decreased, Blood Creatinine Increased, Blood Culture Positive, Blood Fibrinogen Decreased, Blood Glucose Increased, Blood Lactate Dehydrogenase Increased, Blood Pressure Decreased
Adverse event was reported on Feb 20, 2008 by a Male patient taking Depas (View Usage) (Dosage: 1 Mg, Unk) was diagnosed with depression (What is depression?), hypertension, gastric ulcer and. Location: JAPAN , 78 years of age, Patient had the following side effects: aspartate aminotransferase increased, blood bilirubin increased, blood calcium decreased, blood creatinine increased, blood culture positive, blood fibrinogen decreased, blood glucose increased, blood lactate dehydrogenase increased, blood pressure decreased. During the same period patient was treated with DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ), NORVASC (5 Mg/day) (View Norvasc Review and Norvasc Label ), PAXIL (10 G/day) (View Paxil Review and Paxil Label ), TAKEPRON (30 Mg/day) (View Takepron Review and Takepron Label ). Patient was hospitalized.

5476574-9 | Blood Creatine Phosphokinase Increased, Blood Urine Present, Congenital Central Nervous System Anomaly, Decreased Activity, Exercise Lack Of, Feeding Disorder, Hypercreatininaemia
on Sep 27, 2007 Male patient from JAPAN , weighting 8.40 lb, was treated with Depas (View Usage). After Depas was administered, patient had the following side effects: blood creatine phosphokinase increased, blood urine present, congenital central nervous system anomaly, decreased activity, exercise lack of, feeding disorder, hypercreatininaemia. Depas dosage: . During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), LUDIOMIL (View Ludiomil Review and Ludiomil Label ). Patient was hospitalized.

5467785-7 | Blood Creatine Phosphokinase Increased, Blood Urine Present, Congenital Central Nervous System Anomaly, Decreased Activity, Exercise Lack Of, Feeding Disorder, Hypercreatininaemia
on Sep 19, 2007 Male patient from JAPAN , weighting 8.38 lb, was treated with Depas (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, blood urine present, congenital central nervous system anomaly, decreased activity, exercise lack of, feeding disorder, hypercreatininaemia. Depas dosage: . During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), LUDIOMIL (View Ludiomil Review and Ludiomil Label ). Patient was hospitalized.

5401131-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blister, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Coma, Loss Of Consciousness, Overdose, Skin Graft
Patient was taking Depas (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blister, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, coma, loss of consciousness, overdose, skin graft on Jul 24, 2007 from JAPAN Additional patient health information: Female patient , 53 years of age, was diagnosed with suicide attempt and. Depas dosage: Unk, Unk. During the same period patient was treated with HALCION (Unk, Unk) (View Halcion Review and Halcion Label ), LUDIOMIL (Unk, Unk) (View Ludiomil Review and Ludiomil Label ). Patient was hospitalized.

5389819-0 | Blister, Coma, Overdose, Skin Ulcer, Suicide Attempt
Adverse event was reported on Jul 11, 2007 by a Female patient taking Depas (View Usage) (Dosage: ) was diagnosed with suicide attempt and. Location: JAPAN , 53 years of age, After Depas was administered, patient had the following side effects: blister, coma, overdose, skin ulcer, suicide attempt. During the same period patient was treated with HALCION (View Halcion Review and Halcion Label ), LUDIOMIL (View Ludiomil Review and Ludiomil Label ). Patient was hospitalized.

5339738-0 | Blood Creatine Phosphokinase Increased, Blood Urine Present, Congenital Central Nervous System Anomaly, Decreased Activity, Exercise Lack Of, Feeding Disorder, Hypercreatininaemia
on May 23, 2007 Male patient from JAPAN , weighting 8.38 lb, was treated with Depas (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, blood urine present, congenital central nervous system anomaly, decreased activity, exercise lack of, feeding disorder, hypercreatininaemia. Depas dosage: . During the same period patient was treated with SOLANAX (View Solanax Review and Solanax Label ), LUDIOMIL (View Ludiomil Review and Ludiomil Label ). Patient was hospitalized.

5326053-4 | Epistaxis
on May 14, 2007 Male patient from JAPAN , 20 years of age, was diagnosed with insomnia, schizophrenia, parkinsonism and was treated with Depas (View Usage). Patient had the following side effects: epistaxis. Depas dosage: 0.5 Mg, Unk. During the same period patient was treated with AMOBAN (10 Mg, Unk) (View Amoban Review and Amoban Label ), ZYPREXA (15 Mg, Unk) (View Zyprexa Review and Zyprexa Label ), IMPROMEN /00568801/ (4 Mg, Unk) (View Impromen /00568801/ Review and Impromen /00568801/ Label ), AKINETON (7 Mg, Unk) (View Akineton Review and Akineton Label ), NELBON (5 Mg, Unk) (View Nelbon Review and Nelbon Label ).

5324860-5 | Epistaxis
Patient was taking Depas (View Usage). After Depas was administered, patient had the following side effects: epistaxis on May 02, 2007 from JAPAN Additional patient health information: Male patient , 20 years of age, was diagnosed with insomnia, schizophrenia, parkinsonism and. Depas dosage: 0.5 Mg, Unk. During the same period patient was treated with AMOBAN (10 Mg, Unk) (View Amoban Review and Amoban Label ), ZYPREXA (15 Mg, Unk) (View Zyprexa Review and Zyprexa Label ), IMPROMEN /00568801/ (4 Mg, Unk) (View Impromen /00568801/ Review and Impromen /00568801/ Label ), AKINETON (7 Mg, Unk) (View Akineton Review and Akineton Label ), NELBON (5 Mg, Unk) (View Nelbon Review and Nelbon Label ).

5315580-1 | Epistaxis
Adverse event was reported on Apr 27, 2007 by a Male patient taking Depas (View Usage) (Dosage: 0.5 Mg, Unk) was diagnosed with insomnia, schizophrenia, parkinsonism and. Location: JAPAN , 21 years of age, Patient experienced the following unwanted or unexpected effects: epistaxis. During the same period patient was treated with AMOBAN (10 Mg, Unk) (View Amoban Review and Amoban Label ), ZYPREXA (15 Mg, Unk) (View Zyprexa Review and Zyprexa Label ), IMPROMEN /00568801/ (4 Mg, Unk) (View Impromen /00568801/ Review and Impromen /00568801/ Label ), AKINETON (7 Mg, Unk) (View Akineton Review and Akineton Label ), NELBON (5 Mg, Unk) (View Nelbon Review and Nelbon Label ).

5158239-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Blood Urea Increased, C-reactive Protein Increased, Eosinophil Count Increased, Gallbladder Disorder
on Sep 27, 2006 Female patient from JAPAN , 51 years of age, weighting 178.6 lb, was diagnosed with neuralgia and was treated with Depas (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood urea increased, c-reactive protein increased, eosinophil count increased, gallbladder disorder. Depas dosage: 1.5 Mg/day. During the same period patient was treated with WARFARIN SODIUM (4 Mg/day) (View Warfarin Sodium Review and Warfarin Sodium Label ), SELBEX (150 Mg/day) (View Selbex Review and Selbex Label ), TEGRETOL (200 Mg/day) (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

5078921-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb Increased, Cardiac Failure Congestive, Dysstasia, Dysuria, Gamma-glutamyltransferase Abnormal, Hepatitis Fulminant
on Jul 14, 2006 Male patient from JAPAN , 60 years of age, was treated with Depas (View Usage). After Depas was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, cardiac failure congestive, dysstasia, dysuria, gamma-glutamyltransferase abnormal, hepatitis fulminant. Depas dosage: . During the same period patient was treated with LENDORMIN (0.25 Mg/day) (View Lendormin Review and Lendormin Label ), MYSLEE (View Myslee Review and Myslee Label ), LOCHOL (20 Mg/day) (View Lochol Review and Lochol Label ), ACINON (View Acinon Review and Acinon Label ), OLMETEC (Unk, Unk) (View Olmetec Review and Olmetec Label ), CALBLOCK (View Calblock Review and Calblock Label ), FERROMIA (View Ferromia Review and Ferromia Label ), EBASTEL (View Ebastel Review and Ebastel Label ). Patient was hospitalized.

5055978-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb Increased, Cardiac Failure Congestive, Dysstasia, Dysuria, Gamma-glutamyltransferase Abnormal, Hepatitis Fulminant
Patient was taking Depas (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, cardiac failure congestive, dysstasia, dysuria, gamma-glutamyltransferase abnormal, hepatitis fulminant on Jul 14, 2006 from JAPAN Additional patient health information: Male patient , 60 years of age, . Depas dosage: . During the same period patient was treated with LENDORMIN (0.25 Mg/day) (View Lendormin Review and Lendormin Label ), MYSLEE (View Myslee Review and Myslee Label ), LOCHOL (20 Mg/day) (View Lochol Review and Lochol Label ), ACINON (View Acinon Review and Acinon Label ), OLMETEC (Unk, Unk) (View Olmetec Review and Olmetec Label ), CALBLOCK (View Calblock Review and Calblock Label ), FERROMIA (View Ferromia Review and Ferromia Label ), EBASTEL (View Ebastel Review and Ebastel Label ). Patient was hospitalized.

4845657-6 | Arteriosclerosis, Chills, Diarrhoea, Nausea, Tremor
Adverse event was reported on Oct 28, 2005 by a Female patient taking Depas (View Usage) (Dosage: Unk, Unk) was diagnosed with hypertension and. Location: JAPAN , 68 years of age, Patient had the following side effects: arteriosclerosis, chills, diarrhoea, nausea (What is nausea?), tremor. During the same period patient was treated with BENZBROMARONE (View Benzbromarone Review and Benzbromarone Label ), KAMI SHOYO SAN (Unk, Unk) (View Kami-shoyo-san Review and Kami-shoyo-san Label ), DIGESTIVE ENZYMES (View Digestive Enzymes Review and Digestive Enzymes Label ), ESIDRI (3 Df, Qd) (View Esidri Review and Esidri Label ). Patient was hospitalized.

4823540-X | Chills, Diarrhoea, Nausea, Tremor
on Oct 28, 2005 Female patient from JAPAN , 68 years of age, was diagnosed with hypertension and was treated with Depas (View Usage). After Depas was administered, patient had the following side effects: chills, diarrhoea, nausea (What is nausea?), tremor. Depas dosage: . During the same period patient was treated with BENZBROMARONE (View Benzbromarone Review and Benzbromarone Label ), KAMI SHOYO SAN (Unk, Unk) (View Kami-shoyo-san Review and Kami-shoyo-san Label ), DIGESTIVE ENZYMES (View Digestive Enzymes Review and Digestive Enzymes Label ), ESIDRI (3 Df, Qd) (View Esidri Review and Esidri Label ). Patient was hospitalized.

4740541-0 | Abnormal Behaviour, Anorexia, Body Temperature Decreased, Depressed Level Of Consciousness, Dysphagia, Face Oedema, Hallucination, Visual, Myxoedema Coma, Oedema Peripheral
on Aug 05, 2005 Female patient from JAPAN , 86 years of age, weighting 103.6 lb, was diagnosed with psychosomatic disease, gastritis, insomnia, angina pectoris, hypertension and was treated with Depas (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, anorexia, body temperature decreased, depressed level of consciousness, dysphagia, face oedema, hallucination, visual, myxoedema coma, oedema peripheral. Depas dosage: 1.5mg Daily. During the same period patient was treated with ALANTA SF (300mg Daily) (View Alanta Sf Review and Alanta Sf Label ), ROHYPNOL (2mg Daily) (View Rohypnol Review and Rohypnol Label ), FRENADOL (View Frenadol Review and Frenadol Label ), NAPAGELN (View Napageln Review and Napageln Label ), NORVASC (2.5mg Daily) (View Norvasc Review and Norvasc Label ), DIOVAN (40mg Daily) (View Diovan Review and Diovan Label ).

4569409-X | Blood Creatine Phosphokinase Increased, Poor Sucking Reflex, Rhabdomyolysis, Somnolence
Patient was taking Depas (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, poor sucking reflex, rhabdomyolysis, somnolence on Jan 25, 2005 from Additional patient health information: Male patient , weighting 8.82 lb, . Depas dosage: . During the same period patient was treated with SOLANAX (View Solanax Review and Solanax Label ), LUDIOMIL (View Ludiomil Review and Ludiomil Label ). Patient was hospitalized.